Crossmark

Pharmacokinetic Interactions Between Abiraterone, Apalutamide, Darolutamide or Enzalutamide and Antithrombotic Drugs: Prediction of Clinical Events and Review of Pharmacological Information

Crossref DOI link: https://doi.org/10.1007/s10557-023-07453-0

Published Online: 2023-05-01

Published Print: 2024-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Boujonnier, François

Lemaitre, Florian

Scailteux, Lucie-Marie https://orcid.org/0000-0001-7047-9107
Funding

Funding for this research was provided by:

Agence Nationale de Sécurité du Médicament et des Produits de Santé (2021S022)
License Information

Text and Data Mining valid from 2023-05-01

Version of Record valid from 2023-05-01
More Information

Article History

Accepted: 18 April 2023

First Online: 1 May 2023

Declarations

:

: None

: Not applicable to this study.

: All authors have approved and consent to publication.

: The authors declare no competing interests.

: None

Document is current

Any future updates will be listed below